Neoprobe GDS Control Unit, Model Number NPCU3

FDA Device Recall #Z-0070-2021 — Class III — September 7, 2020

Recall Summary

Recall Number Z-0070-2021
Classification Class III — Low risk
Date Initiated September 7, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Devicor Medical Products Inc
Location Cincinnati, OH
Product Type Devices
Quantity 49

Product Description

Neoprobe GDS Control Unit, Model Number NPCU3

Reason for Recall

It was discovered during a documentation review that China has the software version as v5.01 approved for use in China. The current software version on devices distributed in China since 2011 is v6.01.

Distribution Pattern

The products were distributed only to China.

Lot / Code Information

UDI: 00841911100317; Serial Numbers: 122066557 122066558 122066559 122066560 122066561 122666652 123066667 123066668 123066669 123366695 123366696 123366697 123366698 123366699 123366700 123366701 123366702 123266693 123266694 134467282 143367591 144867780 145067796 150367828 150367829 150367840 150467866 150467867 150367830 150367831 150367832 150967913 150967914 151067915 151067916 151067917 151267970 151267971 151267972 151267973 151267974 185269399 185269403 190269421 190469433 190469430 190469428 150467871 150467869

Other Recalls from Devicor Medical Products Inc

Recall # Classification Product Date
Z-1124-2022 Class II HydroMARK Breast Biopsy Marker, Model No. 4010-... Mar 30, 2022
Z-1512-2017 Class II Mammotome Revolve Dual Vacuum Assist Biopsy S... Feb 28, 2017
Z-2211-2016 Class II Mammotome Revolve Dual Vacuum Assist Biopsy Sys... May 19, 2016

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.